These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3118277)

  • 1. Neonatal screening for metabolic and endocrine diseases.
    Tiwary CM
    Nurse Pract; 1987 Sep; 12(9):28-35, 38, 41. PubMed ID: 3118277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal screening for metabolic and endocrine disorders.
    Larsson A
    Ups J Med Sci Suppl; 1987; 44():231-6. PubMed ID: 3481902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early diagnosis of hereditary metabolic diseases in the newborn by means of microbiological Guthrie tests].
    Schmid-Rüter E
    Fortschr Med; 1978 Jun; 96(24):1289-93. PubMed ID: 96002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State screening for metabolic disorders in newborns.
    Stevens MB; Rigilano JC; Wilson CC
    Am Fam Physician; 1988 Apr; 37(4):223-8. PubMed ID: 3358346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5 years of the Austrian program for the early detection of inborn errors of metabolism. Activity report].
    Thalhammer O; Scheibenreiter S; Schön R; Knoll E; Schmierer G
    Wien Klin Wochenschr; 1972; 84():Suppl 2:3-12. PubMed ID: 5085466
    [No Abstract]   [Full Text] [Related]  

  • 6. [25 years Austrian screening program for inborn errors of metabolism at the Vienna University].
    Widhalm K
    Wien Klin Wochenschr; 1992; 104(16):510-3. PubMed ID: 1413809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Austrian programm for the early detection of inborn errors of metabolism].
    Thalhammer O; Scheibenreiter S; Biedl E
    Wien Klin Wochenschr; 1970 Jan; 82(1):1-6. PubMed ID: 5513195
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening of congenital hypothyroidism, phenylketonuria, galactosemia, homocystinuria, and maple syrup urine disease in moderate to severe mentally retarded Chinese children.
    Hsiao KJ; Chen CH; Liu TT; Wu SJ; Plettner C; Clemens P
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):18-22. PubMed ID: 2787833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening and therapy of 6 metabolic diseases of hereditary nature which are possible causes of mental retardation: screening of 1,900,000 newborn infants since the year 1965].
    Menne F
    Clin Ter; 1979 Mar; 88(5):445-59. PubMed ID: 466967
    [No Abstract]   [Full Text] [Related]  

  • 10. Newborn screening in Japan.
    Aoki K
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():80. PubMed ID: 15906702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term follow-up of patients with inborn errors of metabolism detected by the newborn screening program in Japan.
    Aoki K
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():19-23. PubMed ID: 15906687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience].
    Bozkowa K; Cabalska B; Radomyska B; Ołtarzewski M; Lenartowska I
    Med Wieku Rozwoj; 1999; 3(4):529-59. PubMed ID: 10910678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of congenital metabolic diseases with mental retardation].
    Colombo JP
    Rev Otoneuroophtalmol; 1971 Nov; 43(7):328-33. PubMed ID: 5159706
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal screening for inborn errors of metabolism: update.
    Seashore MR
    Semin Perinatol; 1990 Dec; 14(6):431-8. PubMed ID: 2077663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a nine-year phenylketonuria (PKU) screening (author's transl)].
    Menne F
    MMW Munch Med Wochenschr; 1975 Jan; 117(2):63-8. PubMed ID: 164621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening of the Westphalia-Lippe newborns of 1977 for phenylketonuria, histidinemia, homocystinuria and maple syrup disease. Furthermore a pilot study of galactosemia and galactokinase deficiency disease].
    Menne F; Otte HJ; Krüger M; Winterhoff D
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):833-4. PubMed ID: 111089
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and therapy of 6 hereditary, to mental-deficiency-leading, metabolic disorders. 2].
    Menne F; Enzenauer J; Matz D
    Med Klin; 1976 Apr; 71(18):779-85. PubMed ID: 178988
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive cost-utility analysis of newborn screening strategies.
    Carroll AE; Downs SM
    Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of hereditary metabolic diseases (author's transl)].
    Steuer W
    Offentl Gesundheitswes; 1980 Dec; 42(12):949-54. PubMed ID: 6451829
    [No Abstract]   [Full Text] [Related]  

  • 20. Follow-up study of a nation-wide neonatal metabolic screening program in Japan. A collaborative study group of neonatal screening for inborn errors of metabolism in Japan.
    Tada K; Tateda H; Arashima S; Sakai K; Kitagawa T; Aoki K; Suwa S; Kawamura M; Oura T; Takesada M
    Eur J Pediatr; 1984 Aug; 142(3):204-7. PubMed ID: 6468444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.